DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Reclast (Zoledronic Acid) - Current Clinical Trials

 
 



Reclast Related Clinical Trials

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast« [Completed]

PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer [Active, not recruiting]

The Use of Zoledronic Acid to Complex Regional Pain Syndrome [Not yet recruiting]

Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer [Terminated]

Zoledronic Acid Administration in Acute Spinal Cord Injury [Completed]

Double-blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis) [Completed]

Pre-operative Zoledronate in Triple Negative Breast Cancer [Recruiting]

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer [Completed]

Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis [Completed]

Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis [Completed]

Re-treatment of Patients With Paget's Disease Using Zoledronic Acid [Completed]

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid [Active, not recruiting]

Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) [Active, not recruiting]

The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer [Completed]

Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy [Completed]

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period [Completed]

Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid [Active, not recruiting]

Zoledronic Acid in Acute Spinal Cord Injury [Recruiting]

Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy [Completed]

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss [Completed]

Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy [Completed]

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer [Active, not recruiting]

Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer [Not yet recruiting]

A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria [Completed]

The Efficacy of Zoledronic Acid in Modic Changes-related Low Back Pain (LBP) [Completed]

Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer [Terminated]

ZOMETA« (Zoledronic Acid) for Prevention of Bone Metastases [Terminated]

Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions [Completed]

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer [Completed]

Zoledronic Acid in MS-patients With Osteoporosis [Terminated]

Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma [Completed]

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases [Completed]

Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT) [Terminated]

Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients [Completed]

The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer [Active, not recruiting]

Zoledronic Acid in Rheumatoid Arthritis [Recruiting]

Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women [Completed]

Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer [Completed]

N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma [Active, not recruiting]

Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older [Completed]

Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma [Recruiting]

3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs [Completed]

The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta [Recruiting]

Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer [Completed]

Phase 1 Study of Zoledronic Acid in Sickle Cell Disease [Withdrawn]

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma. [Completed]

Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole [Completed]

Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL) [Completed]

Bone Loss Treatment From Adjuvant Zoledronate Efficacy [Recruiting]

Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation [Active, not recruiting]

FES-Rowing Versus Zoledronic Acid to Improve Bone Health in Spinal Cord Injury (SCI) [Completed]

Zoledronate With Atorvastatin in Renal Cell Carcinoma [Completed]

A Multiple Myeloma Trial in Patients With Bone Metastases [Completed]

Effect of Combination of Bortezomib/Dexamethasone/Zoledronic Acid on Bone Disease in Patients With Multiple Myeloma Relapsed After 1-3 Prior Lines of Therapy [Completed]

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I [Terminated]

Prevention of Bone Loss After Acute SCI by Zoledronic Acid [Recruiting]

Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients [Completed]

Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort [Completed]

Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer [Recruiting]

Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid [Completed]

Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density [Completed]

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms [Completed]

The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss [Completed]

Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer [Terminated]

1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions [Recruiting]

Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteoporosis [Completed]

Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer [Active, not recruiting]

Efficacy of Radiotherapy in Combination With Zoledronic Acid on Pain Relief in Bone Metastasis Patients [Recruiting]

Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer [Terminated]

Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis [Completed]

Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer [Active, not recruiting]

Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma [Terminated]

S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone [Withdrawn]

A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss [Terminated]

Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers [Completed]

Zoledronic Acid Treatment of Spontaneous Osteonecrosis of the Knee [Terminated]

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant [Completed]

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer [Completed]

A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects. [Completed]

Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid [Not yet recruiting]

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. [Completed]

A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients [Completed]

Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse [Active, not recruiting]

Efficacy of Zoledronic Acid in Enhancement of Early Stability of Cementless Primary Hip Prosthesis [Completed]

Effect of Zoledronic Acid on Femoral Bone Loss Following Total Hip Arthroplasty [Completed]

Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone [Completed]

To Evaluate the Efficacy of ZOMETA« in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer [Completed]

Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy. [Terminated]

Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCC [Recruiting]

Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer [Completed]

Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation [Completed]

Zoledronic Acid for Osteoporosis in the Elderly [Completed]

Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation [Completed]

Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer [Completed]

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma [Completed]

Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017